Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL.
Tian Z, Shi C, Yang G, Allen JK, Shi Q, Al-Shami A, Olson JW, Smith MG, Chang Q, Kaur J, You J, Lofton TE, Gonzalez MA, Zhang Q, Zha D, Tasian SK, Jain N, Konopleva MY, Heffernan T, Molldrem JJ.
Tian Z, et al. Among authors: al shami a.
Leukemia. 2024 Jan;38(1):226. doi: 10.1038/s41375-023-02090-w.
Leukemia. 2024.
PMID: 38036631
Free PMC article.
No abstract available.